Regeneron Pharmaceuticals reported $2.87B in Gross Profit on Sales for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Agenus AGEN:US USD 22.46M 3.56M
Agios Pharmaceuticals AGIO:US USD 3M 2.15M
Alimera Sciences ALIM:US USD 11.59M 846K
Alnylam Pharmaceuticals ALNY:US USD 223.19M 39.18M
Amgen AMGN:US USD 5.09B 28M
Astellas Pharma 4503:JP JPY 317.61B 24.69B
AstraZeneca AZN:LN USD 8.86B 3M
Biogen BIIB:US USD 2.04B 66.1M
Biomarin Pharmaceutical BMRN:US USD 389.06M 21.62M
Bluebird Bio BLUE:US USD 71K 297K
Bristol Myers Squibb BMY:US USD 8.89B 21M
Eli Lilly And LLY:US USD 5.75B 391.2M
Esperion Therapeutics ESPR:US USD 12.47M 2.81M
Gilead Sciences GILD:US USD 5.99B 346M
GlaxoSmithKline GSK:LN GBP 5.2B 244M
Intercept Pharmaceuticals ICPT:US USD 77.16M 5.72M
IONIS PHARMACEUT IONS:US USD 158.25M 29.21M
Johnson & Johnson JNJ:US USD 15.94B 56M
Kyowa Hakko Kirin 4151:JP JPY 77.74B 1.44B
Merk MRK:US USD 10.47B 610M
Moderna Inc MRNA:US USD 2.26B 1.1B
Neurocrine Biosciences NBIX:US USD 381.8M 8.4M
Novartis NVS:US USD 9.16B 21M
Novartis NOVN:VX USD 9.18B 151M
Pfizer PFE:US USD 14.47B 2.08B
Regeneron Pharmaceuticals REGN:US USD 2.87B 255.4M
Roche Holding ROG:VX 22.73B 924M
Sarepta Therapeutics SRPT:US USD 190.32M 5.38M
Seattle Genetics SGEN:US USD 402.18M 10.78M
Teva Pharmaceutical TEVA:IT USD 1.71B 118M
Ultragenyx Pharmaceutical RARE:US USD 82.07M 999K
United Therapeutics UTHR:US USD 478.8M 41.6M
Vertex Pharmaceuticals VRTX:US USD 2.04B 110.5M
YTE INCY:US USD 774.02M 92.14M